ArticleDrug design, development and therapy2013

Sitagliptin as add-on therapy in insulin deficiency: biomarkers of therapeutic efficacy respond differently in type 1 and type 2 diabetes.

Ottavio Giampietro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.